Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gabriele Mora

Showing results (71-80 of 117) with videos related to

Pageof 12
Sort By:
Annals of Neurology|February 10, 2026
Sex-Specific Genetic Architecture of ALS: Evidence of a Female Protective Effect?Maurizio Grassano, Francesca Palumbo, Gabriele Mora, et al.
JAMA Neurology|July 23, 2014
Amyotrophic lateral sclerosis outcome measures and the role of albumin and creatinine: a population-based studyAdriano Chiò, Andrea Calvo, Giacomo Bovio, et al.
Annals of Neurology|April 3, 2024
Sex Differences in Amyotrophic Lateral Sclerosis Survival and Progression: A Multidimensional AnalysisMaurizio Grassano, Cristina Moglia, Francesca Palumbo, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|August 25, 2022
Exploring the phenotype of Italian patients with ALS with intermediate <i>ATXN2</i> polyQ repeatsAdriano Chio, Cristina Moglia, Antonio Canosa, et al.
Brain : a Journal of Neurology|December 31, 2021
Defective cyclophilin A induces TDP-43 proteinopathy: implications for amyotrophic lateral sclerosis and frontotemporal dementiaLaura Pasetto, Maurizio Grassano, Silvia Pozzi, et al.
Neurology|September 25, 2025
Genetic Variants Associated With Neurodegenerative Disorders in Patients With Amyotrophic Lateral Sclerosis and Phenotypic VariabilityMaurizio Grassano, Emanuele Koumantakis, Francesca F Palumbo, et al.
Neurology|May 18, 2023
Association of Copresence of Pathogenic Variants Related to Amyotrophic Lateral Sclerosis and PrognosisAdriano Chiò, Cristina Moglia, Antonio Canosa, et al.
Muscle & Nerve|January 22, 2011
Repeated courses of granulocyte colony-stimulating factor in amyotrophic lateral sclerosis: clinical and biological results from a prospective multicenter studyAdriano Chiò, Gabriele Mora, Vincenzo La Bella, et al.
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration|February 21, 2013
Randomized double-blind placebo-controlled trial of acetyl-L-carnitine for ALSEttore Beghi, Elisabetta Pupillo, Virginio Bonito, et al.
The Lancet. Neurology|March 17, 2007
Genome-wide genotyping in amyotrophic lateral sclerosis and neurologically normal controls: first stage analysis and public release of dataJennifer C Schymick, Sonja W Scholz, Hon-Chung Fung, et al.
Pageof 12

Showing results (71-80 of 117) with videos related to

Sort By:
Pageof 12
Annals of Neurology|February 10, 2026
Sex-Specific Genetic Architecture of ALS: Evidence of a Female Protective Effect?Maurizio Grassano, Francesca Palumbo, Gabriele Mora, et al.
JAMA Neurology|July 23, 2014
Amyotrophic lateral sclerosis outcome measures and the role of albumin and creatinine: a population-based studyAdriano Chiò, Andrea Calvo, Giacomo Bovio, et al.
Annals of Neurology|April 3, 2024
Sex Differences in Amyotrophic Lateral Sclerosis Survival and Progression: A Multidimensional AnalysisMaurizio Grassano, Cristina Moglia, Francesca Palumbo, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|August 25, 2022
Exploring the phenotype of Italian patients with ALS with intermediate <i>ATXN2</i> polyQ repeatsAdriano Chio, Cristina Moglia, Antonio Canosa, et al.
Brain : a Journal of Neurology|December 31, 2021
Defective cyclophilin A induces TDP-43 proteinopathy: implications for amyotrophic lateral sclerosis and frontotemporal dementiaLaura Pasetto, Maurizio Grassano, Silvia Pozzi, et al.
Neurology|September 25, 2025
Genetic Variants Associated With Neurodegenerative Disorders in Patients With Amyotrophic Lateral Sclerosis and Phenotypic VariabilityMaurizio Grassano, Emanuele Koumantakis, Francesca F Palumbo, et al.
Neurology|May 18, 2023
Association of Copresence of Pathogenic Variants Related to Amyotrophic Lateral Sclerosis and PrognosisAdriano Chiò, Cristina Moglia, Antonio Canosa, et al.
Muscle & Nerve|January 22, 2011
Repeated courses of granulocyte colony-stimulating factor in amyotrophic lateral sclerosis: clinical and biological results from a prospective multicenter studyAdriano Chiò, Gabriele Mora, Vincenzo La Bella, et al.
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration|February 21, 2013
Randomized double-blind placebo-controlled trial of acetyl-L-carnitine for ALSEttore Beghi, Elisabetta Pupillo, Virginio Bonito, et al.
The Lancet. Neurology|March 17, 2007
Genome-wide genotyping in amyotrophic lateral sclerosis and neurologically normal controls: first stage analysis and public release of dataJennifer C Schymick, Sonja W Scholz, Hon-Chung Fung, et al.
Pageof 12